Home Abortion Tags

Abortion

"KFF graphic with white text on a purple background that reads "Interactive Dashboard: Abortion in the United States." The graphic also has photo illustrations of the Supreme Court and abortion medication."

The Abortion in the United States Dashboard is an ongoing research project tracking state abortion policies and litigation following the overturning of Roe v. Wade. It features a continuously-updated map tracking the status of abortion bans across the United States, as well as briefs on topics such as medication abortion, insurance coverage, ballot measures, legal developments, and racial and ethnic disparities. It also offers a jumping off point to the latest national and state-specific abortion policies and statistics. Visit the Dashboard →

View the Latest: Abortion

Filter

List Grid

111-120 of 299 results

  • Litigation Challenging Title X Regulations

    Issue Brief

    This brief provides an overview of the legal challenges to the Trump Administration final Title X regulations and summarizes the key positions of the plaintiffs and HHS.

  • Women Voters Revisited: Inflation, Abortion, and Increased Motivation in the 2024 Election Countdown

    Poll Finding

    In a resurvey of women voters three months later, KFF uncovered substantial shifts in favor of Vice President Harris across a range of key election issues, including the handling of rising household and health care costs as well as enthusiasm for the candidates and motivation to vote. As the presidential election draws near, the survey also showed a pronounced rise in the salience of abortion for women under 30.

  • COVID-19 Puts Medication Abortion in the Spotlight

    News Release

    A new Coronavirus Policy Watch post from KFF explores how state responses to limit abortion access during the COVID-19 pandemic has drawn renewed attention to the provision of medication abortion using telemedicine approaches.  Medication abortion via telemedicine is a method that can be used to safely provide women with access to abortion care while social distancing, preserving personal protective equipment, and limiting risk of exposure to coronavirus. A new telemedicine protocol --“no-test” medication abortions-- has…

  • Medication Abortion Via Telehealth: What You Need to Know About State Regulations

    News Release

    With the country waiting on the Supreme Court’s decision on Dobbs v. Jackson Women’s Health Organization, the case that could overturn Roe v. Wade, many are looking towards telehealth as an alternative to expand access to medication abortion. A new KFF issue brief explains the newly revised Food and Drug Administration (FDA) policy on medication abortion and the differential impact this could have on states by assessing the intersection of federal policy regarding dispensing medication…

  • Legal Challenges to State Abortion Bans Since the Dobbs Decision

    Issue Brief

    This issue brief presents an overview of the legal challenges presented in state courts since the Dobbs ruling in June 2022 and highlights some of the novel strategies that are being used to defend access to abortion in states that have enacted abortion bans.

  • Update on the Status of Medication Abortion and the Courts

    Policy Watch

    This policy watch explains the April 21, 2023 United States Supreme Court's ruling on Alliance for Hippocratic Medicine v. FDA, a case challening the FDA's approval of mifepristone, the medication abortion pill.

  • Challenges to the FDA’s Approval of Medication Abortion Pills Could Curtail Access Throughout the United States

    News Release

    In anticipation of a ruling in a case with enormous implications for access to medication abortion in the United States, a new KFF brief explains the impact of this case, and others filed in federal courts, involving the FDA’s regulation of medication abortion. The case that has gotten the most attention recently is Alliance for Hippocratic Medicine (AHM) v. FDA, filed in November 2022, a challenge to the FDA’s decision to approve mifepristone (the first…